Evercrisp Biosciences
Pengcheng Zhang is a Senior Scientist at Evercrisp Biosciences since June 2022, following a tenure as a Postdoctoral Fellow at UCSF from April 2016 to June 2022 and at the Howard Hughes Medical Institute from June 2015 to March 2016. Previously, Pengcheng Zhang completed a PhD in Cell/Cellular and Molecular Biology at the University of California, Berkeley, from 2009 to 2015, where also served as a Graduate Student Instructor for MCB 110L and MCB 102 courses. Earlier education includes a Bachelor of Science in Biological Sciences from Tsinghua University, earned from 2005 to 2009.
This person is not in any teams
Evercrisp Biosciences
Evercrisp Biosciences, founded by world-renowned scientists who bring expertise and proprietary technology to the company, is currently operating in stealth mode with a substantial Series A commitment from Apple Tree Partners (ATP) to take the company from discovery to proof of concept. Evercrisp is initially focused on high-confidence, genetically validated but "difficult to drug" targets in areas of high unmet need where genome editing can make a significant difference.